Effect of skinfold thickness on arm venous access port in cancer patients

Skin Res Technol. 2023 Oct;29(10):e13482. doi: 10.1111/srt.13482.

Abstract

Background: Currently, skinfold thickness in studies on arm venous access ports and the effect of venous access port application are unknown.

Materials and methods: A total of 256 cancer patients who underwent primary venous access port placement in the Fourth Hospital of Hebei Medical University from September 2022 to March 2023 were selected as the study subjects. Two hundred fifty-six patients were divided into normal skinfold thickness group and high skinfold thickness group according to skinfold thickness. The success rate of primary catheterization of arm venous port catheterization, catheterization operation time, catheterization length and incidence rate of adverse reactions were compared.

Results: There was no significant difference in the basic data between the two groups. There was no significant difference in the success rate of primary catheterization between the two groups (p > 0.05), the catheterization operation time in the normal skinfold thickness group was significantly lower than that in the high skinfold thickness group (p < 0.05), the total length of the implanted catheter in the normal skinfold thickness group was significantly lower than that in the high skinfold thickness group (p < 0.05), and the incidence of adverse reactions in the normal skinfold thickness group was significantly lower than that in the high skinfold thickness group (p < 0.05).

Conclusion: In cancer patients, skinfold thickness can significantly affect the application effect of arm venous port, and normal skinfold thickness for arm venous port has shorter operation time, total length of implanted catheter and lower incidence of adverse reactions.

Keywords: adverse effects; catheter length; port; skinfold thickness.

MeSH terms

  • Arm
  • Catheterization, Central Venous* / adverse effects
  • Catheterization, Central Venous* / methods
  • Humans
  • Neoplasms* / drug therapy
  • Retrospective Studies
  • Risk Factors
  • Skinfold Thickness